Philip Vickers
Direttore/Membro del Consiglio presso AVROBIO, INC.
Patrimonio netto: 5 688 $ in data 30/04/2024
Posizioni attive di Philip Vickers
Società | Posizione | Inizio | Fine |
---|---|---|---|
AVROBIO, INC. | Direttore/Membro del Consiglio | 07/01/2019 | - |
Independent Dir/Board Member | 07/01/2019 | - | |
Northern Mosaic LP
Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Northern Mosaic LP provides biotechnology technology services. The company is headquartered in Toronto, Canada. | Direttore/Membro del Consiglio | - | - |
Solu Therapeutics
Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | Amministratore Delegato | - | - |
Presidente | - | - |
Storia della carriera di Philip Vickers
Precedenti posizioni note di Philip Vickers
Società | Posizione | Inizio | Fine |
---|---|---|---|
REVANCE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 26/02/2015 | 03/05/2023 |
Independent Dir/Board Member | 26/02/2015 | 03/05/2023 | |
Faze Medicines, Inc. /MA)
Faze Medicines, Inc. /MA) Miscellaneous Commercial ServicesCommercial Services Faze Medicines, Inc. provides medical services. The company is headquartered in San Francisco, CA. | Direttore/Membro del Consiglio | 01/01/2021 | 01/11/2022 |
Amministratore Delegato | 01/01/2021 | 01/11/2022 | |
Presidente | 01/01/2021 | 01/11/2022 | |
Northern Biologics, Inc.
Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Direttore/Membro del Consiglio | 13/11/2017 | 01/12/2020 |
Amministratore Delegato | 13/11/2017 | 01/12/2020 | |
Presidente | 13/11/2017 | 01/12/2020 | |
SHIRE | Direttore Tecnico/Scientifico/R&S | 01/10/2010 | 01/06/2017 |
Resolvyx Pharmaceuticals, Inc.
Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | 16/04/2009 | 01/01/2011 |
Direttore Tecnico/Scientifico/R&S | 16/04/2009 | 01/01/2011 | |
Presidente | 01/01/2009 | 01/01/2011 | |
Neusentis Ltd.
Neusentis Ltd. Miscellaneous Commercial ServicesCommercial Services Neusentis Ltd. engages in other business support service activities. The company was founded on October 2, 1997 and is headquartered in Sandwich, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
░░░░░░ ░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░ ░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░░░░ ░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Philip Vickers
University of Salford | Undergraduate Degree |
University of Toronto | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Canada | 4 |
Regno Unito | 3 |
Posizioni
Director/Board Member | 7 |
President | 4 |
Corporate Officer/Principal | 3 |
Settori
Health Technology | 9 |
Commercial Services | 4 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
REVANCE THERAPEUTICS, INC. | Health Technology |
AVROBIO, INC. | Health Technology |
Aziende private | 10 |
---|---|
Resolvyx Pharmaceuticals, Inc.
Resolvyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Resolvyx Pharmaceuticals, Inc. discovers and develops therapeutics for inflammatory diseases. Its products include RX-10001, RX-10045 and RX-20001. The firm's focus is to develop a new class of medicines called Resolvins for the treatment of a range of ophthalmic diseases. The company was founded by Daniel Goodman, Charles N. Serhan, Per Gjorstrup and Thomas E. Van Dyke in June 20, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Boehringer Ingelheim Corp.
Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
Pfizer (St. Louis)
Pfizer (St. Louis) BiotechnologyHealth Technology Part of Pfizer Inc., Pfizer (St. Louis) is a company that provides research services in prescription medicines for humans and animals. The company is based in Chesterfield, MO. | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
Neusentis Ltd.
Neusentis Ltd. Miscellaneous Commercial ServicesCommercial Services Neusentis Ltd. engages in other business support service activities. The company was founded on October 2, 1997 and is headquartered in Sandwich, the United Kingdom. | Commercial Services |
Northern Biologics, Inc.
Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Health Services |
Northern Mosaic LP
Northern Mosaic LP Miscellaneous Commercial ServicesCommercial Services Northern Mosaic LP provides biotechnology technology services. The company is headquartered in Toronto, Canada. | Commercial Services |
Faze Medicines, Inc. /MA)
Faze Medicines, Inc. /MA) Miscellaneous Commercial ServicesCommercial Services Faze Medicines, Inc. provides medical services. The company is headquartered in San Francisco, CA. | Commercial Services |
Solu Therapeutics
Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | Health Technology |
- Borsa valori
- Insiders
- Philip Vickers
- Esperienza